The Business Research Company’s report on the Opioid Use Disorder (OUD) Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
What are the key drivers behind the opioid use disorder (oud) market’s growth in recent years?
The growing number of opioid addiction cases is expected to propel the growth of the opioid use disorder (OUD) market going forward. Opioid addiction refers to a medical condition characterized by compulsive and chronic opioid use that has harmful effects on the body. Opioids can produce a sense of euphoria and pain relief, whose continued usage can lead to the development of tolerance, where higher doses are needed to achieve the same effect, which may lead to opioid use disorder. For instance, in March 2024, according to the Centers for Disease Control and Prevention, a US-based public health agency, the rate of synthetic opioid drug overdosage rose by 4.1%, increasing from 21.8 to 22.7 between 2021 and 2022. Therefore, the growing number of opioid addiction cases drives the growth of the opioid use disorder (OUD) market.
Access Your Free Sample of the Global Opioid Use Disorder (OUD) Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12586&type=smp
How does the future projection of the opioid use disorder (oud) market size compare to its historical growth?
The opioid use disorder (OUD) market size has grown rapidly in recent years. It will grow from $3.96 billion in 2024 to $4.39 billion in 2025 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to increased prescription rates, pain management practices, drug marketing, stigmatization of addiction
The opioid use disorder (OUD) market size is expected to see rapid growth in the next few years. It will grow to $6.94 billion in 2029 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to regulatory interventions, focus on alternative pain management, expansion of treatment access, public health initiatives, . Major trends in the forecast period include technological innovations in treatment, individualized treatment approaches, integrated care models, community-based support programs, early intervention and prevention.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=12586&type=smp
Which key players are shaping the future of the opioid use disorder (oud) market?
Major companies operating in the opioid use disorder (OUD) market include Pfizer Inc., Novartis AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Chiesi Pharmaceuticals S.p.A., Hikma Pharmaceuticals Plc., Mallinckrodt Pharmaceuticals, Indivior Plc., Purdue Pharma L.P, Alkermes Inc., Collegium Pharmaceutical Inc., Vanda Pharmaceuticals Inc., Camurus AB, Tris Pharma Inc., Mylan NV., Orexo US Inc., Zogenix Inc., Rhodes Pharmaceuticals L.P., Omeros Corporation, Braeburn Pharmaceuticals Inc., Adapt Pharma Inc., Titan Pharmaceuticals Inc., BioDelivery Sciences International Inc., AcelRx Pharmaceuticals Inc., KemPharm Inc.
What trends will propel the growth and evolution of the opioid use disorder (oud) market?
Product innovation is a key trend gaining popularity in the opioid use disorder (OUD) market. Major companies operating in the opioid use disorder (OUD) market are developing innovative products to sustain their position in the market. For instance, in May 2023, the U.S. Food and Drug Administration, a US-based federal agency, approved Brixadi (buprenorphine) extended-release injection to treat moderate to severe opioid use disorder (OUD). Brixadi is available in two dosage forms a weekly injection for patients who began treatment with a single dose of a transmucosal buprenorphine product or who are currently taking the medication and a monthly version for those who are already receiving the medication.
Which regions are expected to become dominant players in the opioid use disorder (oud) market?
North America was the largest region in the opioid use disorder (OUD) market in 2024. The regions covered in the opioid use disorder (OUD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report
What are the emerging key segments in the opioid use disorder (oud) market, and how are they evolving?
The opioid use disorder (OUD) market covered in this report is segmented –
1) By Drug Type: Buprenorphine, Naltrexone, Methadone
2) By Route of Administration: Oral, Parenteral
3) By Age Group: 19 To 40, 41 To 60, 61 And Over
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Stores, Online Pharmacies
Subsegments:
1) By Buprenorphine: Suboxone, Buprenorphine Tablets, Buprenorphine Film
2) By Naltrexone: Naltrexone Tablets, Vivitrol
3) By Methadone: Methadone Tablets, Methadone Oral Solution
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12586
What defines the structure and scope of the opioid use disorder (oud) market?
Opioid use disorder (OUD) is a chronic brain disease resulting from prolonged use of opioids, including both prescription painkillers and illegal opioids. Opioid use disorder can develop due to genetic, environmental, and behavioral factors.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
